We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
+1.74%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
AUM
$2.19B
AUM Growth
+$156M
Cap. Flow
+$124M
Cap. Flow %
5.67%
Top 10 Hldgs %
59.25%
Holding
447
New
52
Increased
245
Reduced
121
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 3.65%
2 Financials 1.04%
3 Communication Services 1.02%
4 Healthcare 0.99%
5 Consumer Discretionary 0.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APH icon
326
Amphenol
APH
$186B
$308K 0.01%
2,280
-50
-2% -$6.69K
FDX icon
327
FedEx
FDX
$74.7B
$307K 0.01%
1,063
+87
+9% +$22.8K
ICE icon
328
Intercontinental Exchange
ICE
$79B
$298K 0.01%
1,838
+42
+2% +$6.58K
REZ icon
329
iShares Residential and Multisector Real Estate ETF
REZ
$905M
$291K 0.01%
3,525
+660
+23% +$55.3K
ONEY icon
330
State Street SPDR Russell 1000 Yield Focus ETF
ONEY
$739M
$290K 0.01%
2,552
-68
-3% -$7.69K
HYS icon
331
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.74B
$289K 0.01%
3,051
+120
+4% +$11.4K
AZN icon
332
AstraZeneca
AZN
$262B
$289K 0.01%
1,572
-12
-0.8% -$2.1K
CVS icon
333
CVS Health
CVS
$137B
$286K 0.01%
3,603
+771
+27% +$60.8K
SPYM
334
State Street SPDR Portfolio S&P 500 ETF
SPYM
$157B
$280K 0.01%
+3,493
New +$278K
VNQ icon
335
Vanguard Real Estate ETF
VNQ
$39.6B
$280K 0.01%
3,159
+2
+0.1% +$180
MSTR icon
336
Strategy Inc
MSTR
$34.4B
$279K 0.01%
1,837
+112
+6% +$25.8K
DLS icon
337
WisdomTree International SmallCap Dividend Fund
DLS
$1.04B
$279K 0.01%
3,443
-142
-4% -$11.2K
IDXX icon
338
Idexx Laboratories
IDXX
$44.8B
$278K 0.01%
412
+36
+10% +$24.5K
BSX icon
339
Boston Scientific
BSX
$65.4B
$275K 0.01%
2,889
-78
-3% -$7.65K
SHYD icon
340
VanEck Short High Yield Muni ETF
SHYD
$450M
$275K 0.01%
11,994
-174
-1% -$3.97K
MO icon
341
Altria Group
MO
$124B
$273K 0.01%
4,740
+574
+14% +$34.7K
EMGF icon
342
iShares Emerging Markets Equity Factor ETF
EMGF
$1.79B
$271K 0.01%
4,686
-22
-0.5% -$1.27K
SYK icon
343
Stryker
SYK
$123B
$270K 0.01%
769
+8
+1% +$2.92K
NUMV icon
344
Nuveen ESG Mid-Cap Value ETF
NUMV
$445M
$269K 0.01%
6,891
-23
-0.3% -$893
VHT icon
345
Vanguard Health Care ETF
VHT
$18B
$269K 0.01%
934
-3
-0.3% -$838
TMO icon
346
Thermo Fisher Scientific
TMO
$198B
$267K 0.01%
+461
New +$261K
PSX icon
347
Phillips 66
PSX
$82.9B
$267K 0.01%
2,068
+208
+11% +$28K
QQQM icon
348
Invesco NASDAQ 100 ETF
QQQM
$96.3B
$264K 0.01%
1,043
+26
+3% +$6.57K
DOW icon
349
Dow Inc
DOW
$21.6B
$262K 0.01%
11,205
+183
+2% +$4.21K
VRTX icon
350
Vertex Pharmaceuticals
VRTX
$123B
$258K 0.01%
569
-171
-23% -$73.7K

Similar funds

McAdam LLC's Q4 2025 Portfolio in Review

As of Q4 2025, McAdam LLC held 447 positions worth $2.19B, up 7.7% from $2.03B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

McAdam LLC deployed $124M of net new capital in Q4 2025, opening 52 new positions and adding to 245 existing holdings. Its largest new stake was Franklin Massachusetts Municipal Income ETF: 224,447 shares worth $2.02M.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3.6% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Schwab Emerging Markets Equity ETF, an estimated $613K trimmed.

  • McAdam LLC's largest Q4 2025 buy was Franklin Massachusetts Municipal Income ETF: 224,447 shares worth $2.02M.
  • McAdam LLC added most to Schwab International Equity ETF in Q4 2025, an estimated $17.4M increase.
  • McAdam LLC's biggest Q4 2025 reduction was Schwab Emerging Markets Equity ETF, cutting an estimated $613K.
  • McAdam LLC fully exited Zscaler in Q4 2025, selling an estimated $353K.
  • McAdam LLC's ten largest holdings make up 59% of its $2.19B portfolio in Q4 2025.
  • McAdam LLC opened 52 new positions and closed 16 in Q4 2025.
  • McAdam LLC's portfolio value rose 7.7% quarter-over-quarter to $2.19B.

Based on McAdam LLC's 13F filing for Q4 2025, filed 13 Feb 2026.